CNF1 Antibodies

Santa Cruz Biotechnology offers a broad range of CNF1 monoclonal antibodies for various research applications. CNF1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CNF1, or Cytotoxic Necrotizing Factor 1, is a bacterial protein that modulates host cell signaling pathways, particularly those involved in cytoskeletal dynamics and immune response. The ability of CNF1 to induce actin polymerization and alter cellular functions makes it a significant target for understanding bacterial pathogenesis and host-pathogen interactions. Research focusing on CNF1 continues to reveal new insights into disease mechanisms and potential therapeutic approaches. CNF1 monoclonal antibodies enable precise detection and characterization of CNF1 in diverse experimental settings. Understanding CNF1's role in cellular processes has opened new avenues for investigating bacterial infections and their effects on host cells. CNF1 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing our understanding of bacterial pathogenesis and developing innovative therapeutic strategies.